NCT07124546View on ClinicalTrials.gov

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 28, 2025

Primary Completion Date

May 30, 2027

Study Completion Date

May 30, 2027

Conditions
Malignant Hepatobiliary Neoplasm
Interventions
BEHAVIORAL

Acceptance and Commitment Therapy

Attend ACT-HBC telehealth group sessions

OTHER

Questionnaire Administration

Ancillary studies

OTHER

Telemedicine

Attend ACT-HBC telehealth group sessions

Trial Locations (1)

55905

RECRUITING

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT07124546 - Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers | Biotech Hunter | Biotech Hunter